Connect with us

Latest News

Chile Wind Power Market Outlook to 2030

Published

on

Even as the wind power generation technology is now relatively advanced, the industry is reaching a stage of maturity in the key markets, with some other markets still evolving. In 2019, around 60.4 GW of new wind power capacity was added globally, making it the second-largest year in history and close to the largest year in 2015 (63.8 GW), bringing global cumulative wind power capacity up to 651 GW. The massive wind turbine installation was primarily the result of a strong year in both China and the US – the world’s two largest markets ahead of the expiry of Feed-in Tariffs (FiT) for onshore in the first country and the PTC (extended until the end of 2020 in Dec 2019) in the second. Blackridge Research’s Chile Wind Power Market Outlook report provides comprehensive market analysis on the historical development and targets, the current state of wind power installation scenario, and its outlook.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-62490

The insights in the research report – market data, policies and regulations, project data, company profiles, and competitive landscape analysis – have been derived primarily from our proprietary databases, and offerings – Wind Intelligence Huband Project Tracker Service. The report discusses the impact of the ongoing COVID-19 pandemic on the wind power market, economic trends, and investment & financing scenario in Chile. It gives insights into the market dynamics and the challenges of wind power development in the country. It also comprises significant market development trends and highlights how the socio-economic, environmental, and political factors affect the nation’s wind market.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

intra-abdominal infections market human papillomavirus vaccine market healthcare cybersecurity market hairy cell leukemia drugs market fabry disease treatment market electroceuticals/bioelectric medicine market companion diagnostics market angioedema treatment market leukemia therapeutics market physiotherapy equipment market transdermal drug delivery system market biological drugs market phenylketonuria treatment market postpartum depression treatment market narcolepsy treatment market

Continue Reading
Comments

Latest News

Global Market for Self-Cleaning Coatings: Global Industry, Trends, Market Size, Forecast up to 2030

Published

on

A more recent version of this report is now available, The Global Market for Self-Cleaning Coatings 2020

Self-cleaning coatings are completely transparent and allow for surfaces that are clean, stain resistant and dry, mainly for application on on glass in buildings, solar panels and cars. They can also be used as a waterproof protection for wood, masonry and tarpaulin.

Clean or self-cleaning surfaces can be achieved by two principally different approaches. A photocatalytic coating can be applied to the surface, where the effect of the sun’s ultraviolet rays catalytically breaks down organic dirt. At the same time the surface changes into a superhydrophilic at which time the water spreads evenly over the surface and less drying traces are formed by dripping.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-106044

Another way to manufacture a self-cleaning (bionic) surface in which the surface becomes a super-hydrophobic. Superhydrophobic coatings and films have a wide spectrum of applications; they are used not only for resisting water and fog condensation, but also for preventing contamination.

Report contents include:

Evolution of self-cleaning coatings to now and future prospects.
Development of autonomic and more durable self-cleaning coatings.
Analysis of hydrophobic and hydrophilic surfaces and the emergence of super-hydrophobic and super-hydrophilic coatings technologies.
New developments in self-cleaning coatings including mutli-functional and smart self-cleaning coatings.
Applications and market analysis for self -cleaning coating in Construction, Automotive, Solar, Textiles and Apparel, Consumer Electronics, Medical Coatings, Marine and Household Care sectors.
Revenue forecasts to 2027 across all sectors.
146 company profiles including products and target markets.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Varicose Veins Treatment Devices Market 

Vitamin D Testing Market 

Healthcare Cognitive Computing Market 

Smart Medical Devices Market 

Legal Marijuana Market 

Pharmacovigilance market 

Cancer Therapeutics Market 

Continue Reading

Latest News

The Global Market for Abrasion and Wear Resistant Nanocoatings

Published

on

The surface hardness and the wear resistance of materials can be significantly improved through the use of nanocoatings. The incorporation of nanomaterials improves wear resistance and toughness properties and offers comprehensive corrosion inhibition, as well as meeting stringent regulatory and safety requirements.

There are already numerous commercial applications in mechanical structures and in the machining of materials. The emphasis is on metal treatment, but also promising results have been shown for non-metallic materials. Applications include:

Automotive: Vehicle and protective environments; Scratch-resistant varnishes for automobile paint.
Light metals and various kinds of steel, such as technical parts for cars and aircrafts as well as engine parts.
Food processing
Interior and exterior protection: Mar and scratch resistant coatings for furniture and parquet; Scratch resistant high gloss lacquers on wood and barrier coatings on plastics.
Electronics: Protective layers for semiconductor chips; Transparent plastics such as acrylic glass (PMMA), SAN and polycarbonate, e.g. for plastic walls or displays of mobile phones.
Scratch proof coatings for optical components.
The Global Market for Abrasion and Wear Resistant Nanocoatings Report includes:

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-106045

Market revenues for abrasion and wear resistant nanocoatings.
Detailed analysis of the benefits of using abrasion and wear resistant nanocoatings.
Current products.
53 Abrasion and Wear Resistant Nanocoatings producer profiles.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Liver Cancer Diagnostic Market 

Irritable Bowel Syndrome (IBS) Treatment Market 

Livestock Monitoring Market 

Ligation Devices Market 

Insulin Patch Pumps Market 

Liver Cancer Drugs Market 

Augmented Reality (AR) and Virtual Reality (VR) Market 

In-vitro Toxicology Testing Market 

Kidney Cancer Market 

Internet of Things In Healthcare Market 

Influenza Diagnostics Market 

Immunohistochemistry Market 

Injection Pen Market 

Lysosomal Acid Liapse (LAL) Deficiency Treatment Market 

Liquid Biopsy Market 

Hybrid Imaging Market 

Continue Reading

Latest News

Hormone Replacement Therapy (HRT) Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

The Hormone Replacement Therapy (HRT) market is estimated to represent a global market of USD 20.97 billion by 2019 with growth rate of 7.5%.

Market Dynamics

Menopause is a natural and inevitable event, defined as the final menstrual period. It requires a retrospective clinical diagnosis with ethnic and regional variations. Hormone replacement therapies (HRT) such as systemic estrogen (skin patch, gel, or cream) are considered to be the most effective treatment option in the treatment of menopausal night sweats and hot flashes. These therapies also ease vaginal symptoms of menopause such as itching, burning, and dryness. Due to this fact, women undergoing these therapies has increased considerably over the past few years.

As per the Rose Research Survey (April 2014), women accepting HT therapy has increased considerably, from 4.5 million in 2005 to around 5.0 million in 2014. In addition to this, the growth of this market is attributed to the rise in a number of women in menopausal age coupled with growing patient awareness. For example, according to the International Menopause Society, thousands of women reach menopause experience every day. On another hand, the high cost of therapies coupled with the high risk of adverse reactions posing a potential threat to this industry. For example, as per the study published in PLOS One journal in 2014, testosterone therapy in cardiac patients considerably increase the risk of heart attack.

Replacement Therapy Takeaway

In terms of replacement therapy, the market is categorized as Estrogen, Human Growth Hormone, Testosterone and Thyroid. Estrogen replacement therapy recorded USD 9.58 billion and is expected to soar owing to the approval of new products by the United States Food and Drug Association under this category. Some of the recommended estrogen doses for women with Primary Ovarian Insufficiency (POI) are 1.25 mg conjugated equine estrogen (CEE), 17b-estradiol 2 mg/day, and transdermal estradiol 75–100 mg/day.

Furthermore, Climara, Estradot, Divigel, Elestrin, and EstroGel are some of the commercially available transdermal estrogen products in the U.S. and Canada market by various manufacturers. On contrary, thyroid replacement therapy is considered to be the lowest revenue generating segment and is also pegged to register slowest growth rate i.e. 6.9% in terms of value. Levothyroxine (generic form of thyroxine) is a most commonly prescribed thyroid hormone replacement drug across the globe.

Cumulative effect of COVID-19

As players move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on Hormone Replacement Therapy (HRT) market offers detailed analysis on the emerging market player during this outbreak. The report also included the detailed study related to impact of COVID-19 on the supply chain based on both downstream and upstream markets. The report also includes the future development in the Hormone Replacement Therapy (HRT) Market in relation with the market impact of COVID-19.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-53287

Regional Takeaway

Regionally, the market is divided into North AmericaEuropeAsia Pacific and Rest of the World. Of these, North America captured the highest share, 41.67% of the total market. Drugs such as Premarin, AndroGel, and Levothyroxine have been recorded to gain the maximum prescription within this region. However, Asia Pacific region represents one of the fastest growing regions, enjoying an annual average growth rate over 9.0%. Rising awareness levels coupled with increasing focus of healthcare and government on eradication of hormonal deficiencies are likely to establish a healthy platform for the industry growth in this region.

Key Vendor Takeaway

Companies such as Novo Nordisk, Amgen, Inc., Abbott, Eli Lily and Genentech are covered under research study. The industry experiences a high level of competition. In such fragmented landscape, key players are actively engaged in strategic collaborations to expand their market presence. For instance, in February 2015, Mylan Laboratories signed an agreement for the acquisition of Famy Care.

This acquisition has helped the company to increase its female health product portfolio inclusive of production of hormone replacement drugs, Intra-Uterine Devices (IUD), and contraceptives. Likewise, in December 2014, Pfizer collaborated with OPKO Health. As per the agreement, OPKO would be developing and marketing long-acting human growth hormone (hGH-CTP) (PF-06836922), whereas Pfizer would take care of the post-market studies and development costs.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 Impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
 

SCOPE OF THE REPORT


The scope of this report covers the market by its major segments, which include as follows:

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REPLACEMENT THERAPY
Estrogen
Human Growth Hormone
Testosterone
Thyroid

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY ROUTE OF ADMINISTRATION
Parenteral
Oral
Transdermal
Other

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY DISEASE
Male Hypogonadism
Menopause
Hypothyroidism
Growth Hormone Deficiency
Others

HORMONE REPLACEMENT THERAPY (HRT) MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Enteral Feeding Devices Market 

Dental Equipment Market 

Intravenous Solutions Market 

Fertilization Technique Market 

Artificial Insemination Market 

Medical Oxygen Concentrators Market 

Assisted Reproductive Technology (ART) Market 

Tuberculosis Drugs Market 

STD Diagnostics Market 

Stethoscope Market 

Thalassemia Market 

U.S. Pharmacy Benefit Management (PBM) Market 

Magnetic Resonance Imaging Market 

Infectious Diseases In Vitro Diagnostics Market 

Inflammatory Bowel Disease (IBD) Treatment Market 

Infection Surveillance Solutions Market 

Continue Reading

Latest News

Hemophilia Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

The hemophilia market is estimated to represent a global market of USD 11.62 billion by 2019 with growth rate of 5.3%.

Market Dynamics

Over the eight years to 2016, revenue for the hemophilia industry is anticipated trend higher. Increasing neonatal population is expected to drive the hemophilia diagnosis demand globally. The World Population Meter stated that more than 88.0 billion newborns were reported in 2015 resulting in about 250 births per minute. Of which, approximately 2.8 million infants died within the first month, due to lack of skilled care and proper screening of the babies. The World Health Organization (WHO) also stated that around 2.6 million children died in their first month of life across the globe, which is 7,000 newborn deaths every day. In addition, strong product pipeline will further stimulate the industry growth to great extent over the future period. For example, N9-GP, Concizumab, N8-GP, and Recombinant factor VIIa are some of the bleeding disorder therapeutics under clinical investigations by Novo Nordisk. Despite the industry pipeline increasing, some potential threats exist which will likely to hinder growth prospects going forward. Factors such as high treatment cost coupled with low acceptance of advanced technologies are posing a potential threat to the market.

Types Takeaway

In terms of types, the market is categorized into A, B, C, and other types. Type A accounted for the highest share of the total market. In 2019, the segment recorded 6.8 billion and is expected to dominate the global market over the forecast period. This type is acquired due to the deficiency of clotting factor VIII, which is an anti-hemophilic factor (AHF). According to the National Hemophilia Foundation (NHF), 1 in 5,000 male population affect with type A disorder, which makes it four times more common compared to the type B. As per the Hemophilia News Today, around 4,000 to 5,000 males are affected with type A disease worldwide. Markets besides hemophilia A, B & C is expected to generate the remaining 5.0% of market revenue in 2019.

COVID 19 Impact on hemophilia market
As key companies move from reacting to mitigating the impact of the COVID-19 outbreak, they are keenly focusing on strategies that may result in emerging as strong market player. The published research included the detailed study related to the COVID-19 Impact on the supply chain based on both downstream and upstream markets. The proposed report also includes the future development in the hemophilia Market in relation with the impact of COVID-19 on the market.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-53288

Key Vendor Takeaway

Companies namely, Novo Nordisk, Bayer AG, Pfizer, Inc., Baxalta, and Biogen are profiled. In light of more players entering in this market. the degree of competition has intensified over a couple of years. Competition is based on the development of new therapeutics and co-pay programs.

For example, Grifols provide co-pay programs such as ALPHANATE Copay Program and AlphaNine SD Copay card for this bleeding disorder treatment with an unlimited monetary limit. In addition, companies are engaged in donation activities with government organizations. For instance, in 2016, the World Federation of Hemophilia collected 1.5 million units of anti-hemophilic agents from CSL Behring as a donation on World Hemophilia Day.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 Impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

HEMOPHILIA MARKET, BY TYPES

Hemophilia A
Hemophilia B
Hemophilia C
Others

HEMOPHILIA MARKET, BY TREATMENT
On-demand
Prophylaxis

HEMOPHILIA MARKET, BY THERAPY
Immune Tolerance Induction (ITI) therapy
Replacement therapy
Gene therapy

HEMOPHILIA MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Aerosol Actuator Market 

Acetic acid Market 

Di Methyl Ether Market 

Laboratory Informatics Market 

Connected Health & Wellness Devices Market 

Specialty Generic Pharmaceuticals Market 

Asthma Therapeutics Market 

Antifungal Drugs Market 

Fluorescent In Situ Hybridization Probe (FISH Probe) Market 

Bone Densitometer Market 

Capnography Device market 

Genitourinary Therapeutics Market 

Monoclonal Antibodies Market 

Oxygen Therapy Market Pain Management Devices Market

Continue Reading

Latest News

Durable Medical Equipment (DME) Market: Revenue Growth, Key Players, Qualitative Analysis, Quantitative Analysis, Forecast 2020-2030

Published

on

The Durable Medical Equipment (DME) market is estimated to represent a global market of USD 178.6 billion by 2019 with growth rate of 6.8%.

Market Dynamics

Rising incidences of chronic diseases such as cancer, cardiovascular, neurological and respiratory disorders across the world drive the demand for durable medical equipment. For example, according to the Centers for Disease Control and Prevention (CDC), approximately 630,000 U.S. people (1 in every 4 death) die due to the cardiovascular problem every year. Additionally, as per the International Agency for Research on Cancer, around 14.1 million cancer cases were reported in 2012 and more than 32 million people are living with cancer worldwide.

In addition, strategic acquisitions and partnership with government and healthcare players in order to provide affordable healthcare will support the industry development significantly. For instance, in February 2019, Hill-Rom acquired Mortara Instrument, Inc., a Wisconsin-based medical device manufacturer to increase their medical device product portfolio. However, low reimbursement rates are one of the restraints, pulling back the market growth to some extent. For instance, Medicare, the U.S. government’s official health insurance program, consider only medically required durable equipment for reimbursement purpose.

Types Takeaway

In terms of types, the market is divided into Monitoring and Therapeutic Devices, Personal Mobility Devices, and Bathroom Safety Devices and Medical Furniture. In terms of value, monitoring and therapeutic devices accounted for the highest share of the overall market. This segment has captured more than 87% share of the global market in 2019. This product category is further bifurcated into Blood Glucose Monitors, Continuous Positive Airway Pressure (CPAP), Oxygen Equipment, Infusion Pumps, Continuous Passive Motion (CPM), and others. Estimated CAGR for these products during 2019-2021-2027 range between 6-8%, with the oxygen equipment witnessing the highest growth. Devices such as glucose monitors and CPM has experienced a high level of technological change which has helped this segment to capture the highest share compared to others. Personal mobility segment is further categorized as Scooters, Wheelchairs, Walker and Rollators, and others.

Cumulative Effect of COVID-19 Outbreak
The proposed report includes an additional chapter on the impact of COVID 19 on the Durable Medical Equipment (DME) market.This chapter will highlight various factors on how the Covid-19 is affecting this industry, market trends, future outlook and recovery analysis.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-53289

Regional Takeaway

Regionally, developed regions such as North America and Europe accounted for the largest share of the global industry. Factors such as increasing obese & geriatric population, increasing demand for regular-monitoring devices by fitness-oriented citizens, and rising demand for independent living are expected to augment the regional growth. On contrary, lack of advancements has resulted in a scarcity of cost-effective medical equipment in developing regions such as Middle East & Africa. At present, there are a limited number of technologically advanced medical devices available, and that too in select pockets of the MEA countries. There is a huge gap between the needs of the consumer and what is available in the MEA market.

Key Vendor Takeaway

The competition in the global market has intensified over a couple of years on account of the entry of various small scale and large scale players. Companies namely Stryker Corporation, Invacare Corporation, Drive Medical, Carex Health Brands, Inc., and Medline Industries are actively engaged in developing innovative and new products. For instance, in February 2019, Invacare Corporation introduced high-active custom wheelchairs belonging to the küschall brand, namely, küschall Champion, küschall K-Series attract, and küschall Advance in the U.S. market to capture large customer base.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 Impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

DURABLE MEDICAL EQUIPMENT (DME) MARKET, BY TYPES
Monitoring and Therapeutic Devices
Personal Mobility Devices
Bathroom Safety Devices and Medical Furniture

DURABLE MEDICAL EQUIPMENT (DME) MARKET, BY END USE
Home Healthcare
Hospital Settings
Others

DURABLE MEDICAL EQUIPMENT (DME) MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:Hina Miyazu

Shibuya Data Count
Email: sales@sdki.jp
Tel: + 81 3 45720790

Related Posts:

Aromatherapy Market 

Deep brain stimulation (DBS) Market 

Cell Line Development Market 

Ophthalmic devices market 

Drug Device Combination Market 

In Vitro Diagnostics Market 

Transdermal Drug Delivery Devices Market 

Animal Imaging market 

Digital Pathology Market 

Patient Handling Equipment Market 

Medical Marijuana Market 

Sports Medicine Market 

Cloud Infrastructure Market 

Continue Reading

Trending